Response to HBV vaccine in relation to vaccine dose and anti-HCV positivity: a New South Wales correctional facilities' study

被引：14

作者：

Awofeso, N ^{[1
]}

Levy, M ^{[1
]}

Harper, S ^{[1
]}

Jones, M ^{[1
]}

Hayes, M ^{[1
]}

Douglas, J ^{[1
]}

Fisher, M ^{[1
]}

Folpp, D ^{[1
]}

机构：

[1] New S Wales Correct Hlth Serv, Matraville, NSW 2036, Australia

来源：

VACCINE | 2001年 / 19卷 / 30期

关键词：

HB vaccination; hepatitis C; vaccine dose;

D O I：

10.1016/S0264-410X(01)00172-4

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Currently, about two-thirds of inmates in NSW correctional facilities have a history of injection drug use, and about half have serological evidence of exposure to hepatitis C virus. The introduction of an accelerated hepatitis B vaccination program (0-1-2 months) in 1998, using a 20 mug/dose vaccine was necessitated by the need to vaccinate eligible inmates in this high-risk environment characterised by rapid client mobility. Since 1999, both 10 and 20 mug doses of vaccine were introduced. We found that sero-response rates were not significantly influenced by HCV antibody status, but were significantly lower in cohorts of inmates vaccinated with the 10 mug dose of vaccine. (C) 2001 Elsevier Science Ltd. All rights reserved.

引用

页码：4245 / 4248

页数：4

共 18 条

[1] Prevalence of exposure to hepatitis C virus among prison inmates, 1999 [J].

Awofeso, N ;

Harper, SE ;

Levy, MH .

MEDICAL JOURNAL OF AUSTRALIA, 2000, 172 (02) :94-94

[2]

Awofeso N, 2001, TOB CONTROL, V10, P84

[3] Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory [J].

Banatvala, J ;

Van Damme, P ;

Oehen, S .

VACCINE, 2000, 19 (7-8) :877-885

[4] HEPATITIS-B VACCINATION IN PRISONS - THE CATALONIAN EXPERIENCE [J].

BAYAS, JM ;

BRUGUERA, M ;

MARTIN, V ;

VIDAL, J ;

RODES, J ;

SALLERAS, LY .

VACCINE, 1993, 11 (14) :1441-1444

[5] Methadone-maintained former heroin addicts, including those who are anti-HIV-1 seropositive, comply with and respond to hepatitis B vaccination [J].

Borg, L ;

Khuri, E ;

Wells, A ;

Melia, D ;

Bergasa, NV ;

Ho, A ;

Kreek, MJ .

ADDICTION, 1999, 94 (04) :489-493

[6] Hepatitis B and C in New South Wales prisons: Prevalence and risk factors [J].

Butler, TG ;

Dolan, KA ;

Ferson, MJ ;

McGuinness, LM ;

Brown, PR ;

Robertson, PW .

MEDICAL JOURNAL OF AUSTRALIA, 1997, 166 (03) :127-130

[7] Exposure to hepatitis A virus among blood donors, injecting drug users and prison entrants in Victoria [J].

Crofts, N ;

Cooper, G ;

Stewart, T ;

Kiely, P ;

Coghlan, P ;

Hearne, P ;

Hocking, J .

JOURNAL OF VIRAL HEPATITIS, 1997, 4 (05) :333-338

[8] The influence of psychological stress on the immune response to vaccines [J].

Glaser, R ;

Kiecolt-Glaser, JK ;

Malarkey, WB ;

Sheridan, JF .

NEUROIMMUNOMODULATION: MOLECULAR ASPECTS, INTEGRATIVE SYSTEMS, AND CLINICAL ADVANCES, 1998, 840 :649-655

[9] VACCINATION AGAINST HEPATITIS-B - COMPARISON OF 3 DIFFERENT VACCINATION SCHEDULES [J].

JILG, W ;

SCHMIDT, M ;

DEINHARDT, F .

JOURNAL OF INFECTIOUS DISEASES, 1989, 160 (05) :766-769

[10]

KERMODE M, 1998, AUST NZ J PUBL HEAL, V22, P264

← 1 2 →